Posted on 20/11/2009 in Pharmaceutical Company Product News Archimedes Pharma this week won the Scrip Award SME Pharmaceutical Company of the Year, it has revealed.
The Scrip Award is voted for by a judging panel comprised of professionals from global pharmaceutical firms and includes criteria such as a company's performance, revenue growth, shareholder value and possible new deals.
Reasons cited for Archimedes Pharma's success include the popularity of its NasalFent spray, which is designed to relieve pain in cancer sufferers.
Chief executive officer of Archimedes Pharma Richard de Souza said: "2009 has been a tough year for the life sciences sector, but against this backdrop we have worked extremely hard to meet key milestones for the company and its shareholders."
This news comes after Archimedes Pharma filed an application with the Food and Drug Administration for NasalFent in September 2009.
Speaking at the time, Mr de Souza stated that this year has been "fundamental" for raising the profile of the product.
Other news stories from 20/11/2009
Read more in the Zenopa News Archive
How this news is generated
|
